Impressed by the success of the FDA’s breakthrough therapy designation, U.K. regulators are considering a similar effort to speed the path for promising drugs, according to an industry group. The nation’s government is in the midst of “active discussion across Whitehall” on a plan that would fast-track certain treatments, according to the trade group U.K. […]
↧